Faire progresser les écosystèmes d'essai des thérapies cellulaires et géniques dans la région Asie-Pacifique
Webinar Overview
À la frontière entre plusieurs disciplines scientifiques, la thérapie cellulaire et génique dévoile son plein potentiel pour traiter les maladies incurables et ainsi transformer la vie des patients. Bien que dynamisées par l'élan des opportunités d'investissement, les entreprises biotechnologiques de la région Asie-Pacifique sont confrontées à des défis en termes d'opérations cliniques et d'accès aux marchés.
Join our online webinar and gain an in-depth understanding of the opportunities of cell and gene therapeutic product development and market entry strategies in this fast-evolving industry. Investigate the prospectus of operational excellence, investigator engagement, as well as patient recruitment to accelerate the journey. Additionally, explore Fortrea's solution for navigating the complexity of clinical studies in cell and gene therapy and understand the best practices in supporting the success of both emerging biotech and large pharmaceutical sponsors.
addition to the online presentations, feel free to book a seat at the actual site in Seoul, Korea, to join face-to-face discussions with Fortrea experts and key stakeholders covering the cell and gene therapy ecosystem. Share insights from various facets on advancing CGT clinical development in Asia Pacific.
Learnings
- In-depth insights towards the evolving regulatory framework for cell and gene therapy in the US as well as the major CGT market in APAC regions.
- Navigating the complexity in cell and gene therapy studies, leveraging resources on hospital infrastructure, clinicians, as well as chain logistics to ease the burden of investigators and sites.
- Exploring Fortrea’s dedicated infrastructure and expertise in the CGT arena.
Programme
15:00-15:15 | Landscape & Regulatory
Global CGT landscape and navigating the Regulatory Landscape
15:15-15:30 | Insights from sites
Addressing the Complexities of Conducting CGT clinical trials
15:30-15:45 | Commercialization
Advancing cutting-edge therapies from bench-to-bedside
15:45-16:00 | Operation Excellence
From Benchtop to Patient -Manufacturing Considerations for Clinical Development of Advanced Therapeutics
16:00-16:30 | Panel Discussion
Advancing CGT trial ecosystem in APAC
Related insights
More from our insights
Explorer les applications de la thérapie CAR-T en dehors de l'oncologie : stratégies pour appliquer les enseignements
Regarder le webinaire
Repousser les limites des thérapies cellulaires et géniques
Discover Fortrea's advancements in cell and gene therapy. Read our blog for insights into the latest breakthroughs and innovative treatments in genetic medicine.
En savoir plus
Examining the role of genetic counselors
Learn how to genetic counselors promote patient centricity in cell and gene therapy clinical trials.
Download White Paper
The journey of Advanced Therapy Medicinal Product (ATMP) studies in the European Union
Sponsors developing combined advanced therapy medicinal products (CATMPs) play an important role in advancing potentially groundbreaking opportunities and addressing unmet healthcare needs.
En savoir plus